[Beta-adrenergic blockade with INPEA in arrhythmia].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000494:pharmacology / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D002648:Child; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009596:Nitrophenols / Q000494:pharmacology / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000605:Amino Alcohols; D009596:Nitrophenols
El bloqueo beta-adrenérgico con "INPEA" en las arritmias.